HZNP logo

Horizon Therapeutics Public Limited Company (HZNP)

Profile

Full Name

Horizon Therapeutics Public Limited Company

Ticker

NASDAQ: HZNP

Exchange

NASDAQ

Sector

Healthcare

Industry

General Drug Manufacturers

Country

Ireland

IPO

July 28, 2011

Indexes

Not included

Website

http://www.horizontherapeutics.com

Employees

2190

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.63B(+12.48% YoY)

Annual EPS

$2.22(-2.20% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    -
    HZNP price value is unknown

    30-Day Relative Volume

    -
    HZNP 30-day relative volume value is unknown

    Price Performance

    Price Most recent change

    -
    HZNP price change on Jan 1, 1 is unknown

    Price YTD change

    -
    HZNP price ytd change is unknown

    Price 1-year change

    -
    HZNP price 1-year change is unknown

    Price 3-year change

    -
    HZNP price 3-year change is unknown

    Price Range

    Price All-time high

    $116.30
    HZNP price is currently at an all-time high

    Price 3-year low

    $116.30
    HZNP price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    HZNP market capitalization value is unknown

    Market cap 3-year change

    -
    HZNP market capitalization 3-year change is unknown

    Market cap All-time high

    $26.63B
    HZNP market capitalization is currently at an all-time high

    Market cap sector rank

    -
    HZNP market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    HZNP shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    -0.58%
    HZNP shares outstanding is down -0.58% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -
    HZNP beta value is unknown

    200-day SMA

    -
    HZNP SMA 200 is unknown

    50-day SMA

    -
    HZNP SMA 50 is unknown

    RSI

    -
    HZNP 14-day relative strength index value is unknown

    Volume

    -
    HZNP 30-day relative volume value is unknown

    ATR

    -
    HZNP average true range value is unknown

    10-day Historical Volatility

    -
    HZNP 10-day historical volatility value is unknown

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.63B
    HZNP annual revenue is $3.63 billion

    Revenue Analysts estimate

    $3.77B
    HZNP annual revenue is currently -3.77% lower than the consensus analysts' forecast

    Revenue 1-year change

    +12.48%
    HZNP annual revenue is up +12.48% year-on-year

    Revenue Sector rank

    -
    HZNP annual revenue is unknown

    EPS

    EPS

    $2.22
    HZNP annual earnings per share is $2.22

    EPS Analysts estimate

    $4.64
    HZNP annual earnings per share is currently -52.16% lower than the consensus analysts' forecast

    EPS 1-year change

    -2.2%
    HZNP annual earnings per share is down -2.2% year-on-year

    EPS Sector rank

    -
    HZNP annual earnings per share is unknown

    Profit

    Gross profit

    $2.71B
    HZNP annual gross profit is $2.71 billion

    Gross margin

    74.64%
    HZNP annual gross profit margin is 74.64%

    Operating profit

    $729.83M
    HZNP annual operating income is $729.83 million

    Operating margin

    20.11%
    HZNP annual operating profit margin is 20.11%

    Net income

    $521.48M
    HZNP annual net profit is $521.48 million

    Net margin

    14.37%
    HZNP annual net profit margin is 14.37%

    Expenses

    Total expenses

    $2.90B
    HZNP annual total expenses is $2.90 billion

    Operating expenses

    $1.98B
    HZNP annual total operating expenses is $1.98 billion

    Cost of goods sold

    $920.20M
    HZNP annual cost of goods sold is $920.20 million

    Selling, general & administrative expenses

    $1.54B
    HZNP annual SGA is $1.54 billion

    Depreciation and amortization

    $390.39M
    HZNP annual depreciation & amortization is $390.39 million

    Interest expense

    $83.71M
    HZNP annual interest expense is $83.71 million

    Income tax

    $5.45M
    HZNP annual income tax is $5.45 million

    EBIT & EBITDA

    EBIT

    $610.64M
    HZNP annual earnings before interest & taxes is $610.64 million

    EBITDA

    $1.00B
    HZNP annual EBITDA is $1.00 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $9.11B
    HZNP annual total assets is $9.11 billion

    Non current assets

    $4.45B
    HZNP annual long term assets is $4.45 billion

    Current assets

    $3.65B
    HZNP annual total current assets is $3.65 billion

    Cash and cash equivalents

    $2.35B
    HZNP annual cash & cash equivalents is $2.35 billion

    Accounts receivable

    $676.35M
    HZNP annual accounts receivable is $676.35 million

    Inventory

    $169.56M
    HZNP annual inventory is $169.56 million

    Liabilities

    Total liabilities

    $4.04B
    HZNP annual total liabilities is $4.04 billion

    Long term liabilities

    $3.09B
    HZNP annual total long term liabilities is $3.09 billion

    Current liabilities

    $949.14M
    HZNP annual total current liabilities is $949.14 million

    Accounts payable

    $155.80M
    HZNP annual accounts payable is $155.80 million

    Debt

    Total debt

    $2.58B
    HZNP annual total debt is $2.58 billion

    Total debt 1-year change

    -0.32%
    HZNP annual total debt is down -0.32% year-on-year

    Long term debt

    $2.56B
    HZNP annual long term debt is $2.56 billion

    Short term debt

    $16.00M
    HZNP annual short term debt is $16.00 million

    Equity & Capital

    Shareholders equity

    $5.07B
    HZNP annual stockholders equity is $5.07 billion

    Book value

    $5.07B
    HZNP annual book value is $5.07 billion

    Retained earnings

    $590.01M
    HZNP annual retained earnings is $590.01 million

    Working capital

    $2.70B
    HZNP annual working capital is $2.70 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $1.26B
    HZNP annual cash flow from operations is $1.26 billion

    Cash from operations 1-year change

    +21.5%
    HZNP annual cash flow from operations is up +21.5% year-on-year

    Cash from investing

    -$134.00M
    HZNP annual cash flow from investing activities is -$134.00 million

    Cash from investing 1-year change

    +95.52%
    HZNP annual cash flow from investing activities is up +95.52% year-on-year

    Cash from financing

    -$347.96M
    HZNP annual cash flow from financing activities is -$347.96 million

    Cash from financing 1-year change

    -123.67%
    HZNP annual cash flow from financing activities is down -123.67% year-on-year

    CAPEX

    CAPEX

    $126.28M
    HZNP annual capital expenditures is $126.28 million

    CAPEX 1-year change

    -1.48%
    HZNP annual capital expenditures is down -1.48% year-on-year

    Free Cash Flow

    Free cash flow

    $1.13B
    HZNP annual free cash flow is $1.13 billion

    Free cash flow 1-year change

    +24.75%
    HZNP annual free cash flow is up +24.75% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    74.64%
    HZNP annual gross profit margin is 74.64%

    Operating margin

    20.11%
    HZNP annual operating profit margin is 20.11%

    Net margin

    14.37%
    HZNP annual net profit margin is 14.37%

    ROA & ROE

    ROA

    5.86%
    HZNP annual return on assets is 5.86%

    ROE

    10.70%
    HZNP annual return on equity is 10.70%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    HZNP price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    HZNP price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    HZNP price to book ratio value is unknown

    PB ratio Sector rank

    -
    HZNP price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    HZNP price to sales ratio value is unknown

    PS ratio Sector rank

    -
    HZNP price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    HZNP enterprise value value is unknown

    Enterprise value Sector rank

    -
    HZNP enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    HZNP EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    HZNP EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.85
    HZNP annual current ratio is 3.85

    Quick ratio

    3.67
    HZNP annual quick ratio is 3.67

    Leverage

    Debt to equity

    0.51
    HZNP annual debt to equity ratio is 0.51

    Interest coverage ratio

    7.30
    HZNP annual interest coverage ratio is 7.30

    Risk & Stability

    Piotroski F-Score

    8
    HZNP piotroski f-score is 8

    Altman Z-Score

    -
    HZNP altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Dec 13, 22 Wells Fargo
    Equal-Weight
    Dec 13, 22 SVB Leerink
    Market Perform
    Dec 13, 22 Guggenheim
    Neutral
    Dec 13, 22 BMO Capital
    Market Perform
    Dec 12, 22 Stifel
    Hold
    Dec 7, 22 Piper Sandler
    Overweight
    Nov 3, 22 SVB Leerink
    Outperform
    Nov 1, 22 HC Wainwright & Co.
    Neutral
    Oct 25, 22 Piper Sandler
    Overweight
    Aug 4, 22 UBS
    Neutral

    Institutional Ownership

    Screeners with HZNP included

    No data
    • What is the ticker symbol for Horizon Therapeutics Public Limited Company?
    • Does Horizon Therapeutics Public Limited Company pay dividends?
    • What sector is Horizon Therapeutics Public Limited Company in?
    • What industry is Horizon Therapeutics Public Limited Company in?
    • What country is Horizon Therapeutics Public Limited Company based in?
    • When did Horizon Therapeutics Public Limited Company go public?
    • Is Horizon Therapeutics Public Limited Company in the S&P 500?
    • Is Horizon Therapeutics Public Limited Company in the NASDAQ 100?
    • Is Horizon Therapeutics Public Limited Company in the Dow Jones?
    • When was Horizon Therapeutics Public Limited Company's last earnings report?
    • When does Horizon Therapeutics Public Limited Company report earnings?

    What is the ticker symbol for Horizon Therapeutics Public Limited Company?

    The ticker symbol for Horizon Therapeutics Public Limited Company is NASDAQ:HZNP

    Does Horizon Therapeutics Public Limited Company pay dividends?

    No, Horizon Therapeutics Public Limited Company does not pay dividends

    What sector is Horizon Therapeutics Public Limited Company in?

    Horizon Therapeutics Public Limited Company is in the Healthcare sector

    What industry is Horizon Therapeutics Public Limited Company in?

    Horizon Therapeutics Public Limited Company is in the General Drug Manufacturers industry

    What country is Horizon Therapeutics Public Limited Company based in?

    Horizon Therapeutics Public Limited Company is headquartered in Ireland

    When did Horizon Therapeutics Public Limited Company go public?

    Horizon Therapeutics Public Limited Company's initial public offering (IPO) was on July 28, 2011

    Is Horizon Therapeutics Public Limited Company in the S&P 500?

    No, Horizon Therapeutics Public Limited Company is not included in the S&P 500 index

    Is Horizon Therapeutics Public Limited Company in the NASDAQ 100?

    No, Horizon Therapeutics Public Limited Company is not included in the NASDAQ 100 index

    Is Horizon Therapeutics Public Limited Company in the Dow Jones?

    No, Horizon Therapeutics Public Limited Company is not included in the Dow Jones index

    When was Horizon Therapeutics Public Limited Company's last earnings report?

    Horizon Therapeutics Public Limited Company's most recent earnings report was on November 2, 2023

    When does Horizon Therapeutics Public Limited Company report earnings?

    The date for Horizon Therapeutics Public Limited Company's next earnings report has not been announced yet
    On this page